Dr Jehangir Din

Dr Jehangir Din was appointed Clinical Director at the Dorset Heart Clinic in 2019.

Dorset Heart Clinic (DHC) is an operating company of Regent’s Park and a formal LLP partnership with The Royal Bournemouth & Christchurch Hospitals NHS Foundation Trust. DHC has been operating since 2016.

Dr Din completed his undergraduate medical degree at the University of Edinburgh, together with a 1st class intercalated BSc honours degree. He undertook his cardiology training at Edinburgh Heart Centre, training in general cardiology, cardiac CT, and sub-specialising in percutaneous coronary intervention and stenting. Dr Din was awarded the British Cardiovascular Intervention Society Vancouver Island Fellowship, where he obtained further high-volume experience in advanced coronary intervention. He returned to the UK in 2012 after being appointed Consultant Interventional Cardiologist at the Royal Bournemouth Hospital.

Dr Din sees patients with general cardiology problems including hypertension, chest pain, palpitations, heart failure and heart valve disease. His sub-speciality interest is coronary intervention and stenting, and he has particular expertise in performing coronary procedures via the radial (wrist) artery. He undertakes intra-coronary imaging, pressure-wire measurements, and complex intervention including rotational and laser atherectomy with excellent outcomes.

Dr Din has an interest in quality and safety and is the Lead for Clinical Governance at the Dorset Heart Clinic. He is also a member of the British Cardiovascular Society, British Cardiovascular Intervention Society, and a Fellow of the Royal College of Physicians.

Research

Dr Din’s research interests include diet and heart disease, and he completed a British Heart Foundation funded research fellowship investigating the vascular effects of omega 3 fatty acids in man for which he was awarded his MD by the University of Edinburgh. He has published widely in international peer-reviewed medical journals and has presented at national and international conferences. He is a local principal investigator for multi-centre clinical trials and maintains an active interest in cardiac and interventional research.